richard a gonzalez biography

[32] In the same month the company announced it would co-commercialize Argenx's preclinical immunotherapy, ARGX-115. Alvarez Lemus, and R.D.Gonzalez. [25] In June, Abbvie announced it would acquire TeneoOne and its lead compound TNB-383B. WebRichard Gonzalezis 72 years old and was born on 04/14/1950. Richard A. Gonzalez is the Chairman of the Board, Chief Executive Officer of the Company. T.Lopez, E.Ortiz, P.Quintana and R.D.Gonzalez, Colloid & Surfaces A: Physicochem.Eng. It originated as a spin-off of Abbott Laboratories . in Surface Science and Catalysis 130, 2687-2792 (2000). Mr. Gonzalez, 58, was a research biochemist at the University of Miami School of Medicine and attended the University of Houston, majoring in biochemistry, according to the company's website. The company's stock fell 6 percent following an earnings report that included a $2.2 billion charge related to the opioid deal. Sarah Arsenault and Richard D Gonzalez. Once logged in, you can add biography in the database. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. Richard A. Gonzalez (born 21 January 1954), is the chairman of the board and CEO of the pharmaceutical company AbbVie. Ms. Brotz declined to say exactly when Abbott learned about the errors, except to say it was some time ago. The company corrected the information on its website immediately after the errors were discovered, she said. The compound is a BCMA-targeting immunotherapeutic for relapsed or refractory multiple myeloma. Mr. Gonzalez's experience and knowledge enable him to contribute to AbbVie's board key insights into strategic, management, and operational matters. Department of Chemical and Biomolecular Engineering Applied Mechanics and Materials, Vol 15,121-126, (2009). In March 2020, as the COVID-19 pandemic developed into an international crisis, the Israeli government announced that it would force AbbVie to license its patents for Kaletra, the brand name of lopinavir/ritonavir, a fixed dose combination medication for the treatment and prevention of HIV/AIDS which was also thought to have some applicability to fighting COVID-19. This approach, which has been used successfully, in both model laboratory animals and in the case of chemotherapy, on humans, has shown promising results. M.J. Uddin, D. Mondal, C.A.Morris, T.Lopez, U.Diebold and R.D.Gonzalez. An Implantable Sol-Gel Titania-Silica Carrier System for the Controlled Release of Anticonvulsants. Kinetic study of the controlled release of VPA and DPH antiepileptic drugs using biocompatible nanostructured sol-gel titania. WebRichard A. Gonzalez was born c. 1968. Get notified the next time Richard A. Gonzalez buys or sells AbbVie stock. Best of 2022 Top 250 Movies Most Popular Movies Top 250 TV Shows Most Popular TV Shows Most Popular Video Games Most Popular Music Videos Most Popular Podcasts. Chart Data in Insider Trading History Table. [2] A corporate press release stated that the name AbbVie derived from a combination of "Abbott" with "vie," intended as a reference to a Latin root meaning "life. [47][48], In July 2022 the company agreed to pay up to $2.37 billion to settle U.S. lawsuits against its Allergan unit over the marketing of opioid painkillers. Email: sse@tulane.edu, The Herman and George R. Brown Professor Emeritus. T.Lopez, E.Ortiz Islas, A.Hernandez, J. Manjarrez, F.Rodriguez-Reinoso, A.Sepulveda, and R.D.Gonzalez. 19(3-4) 203-335 (2002). WebAbbVie is an American publicly traded biopharmaceutical company founded in 2013. There are 7 older and 24 younger executives at Abbvie Inc. Richard A. Gonzalez occupies the position of Chairman & Chief Executive Officer of AbbVie, Inc. WebRichard A. Gonzalez is known for Bliss (2019), As Advertised (2014) and When Noise Met Sound: Apocalyptica (2016). Learn More on Richard A. Gonzalez's contact information. Learn More on Richard A. Gonzalez's contact information. Prices hit a 10-year high; as copper jumped 79% in the past year. (2009). Albert Gonzalez was born on 1981 in . Trending. Prabook is a registered trademark of World Biographical Encyclopedia, Inc. Richard A. Gonzalez, pharmaceutical executive. See also Other Works | Publicity WebRichard Gonzalez in New York We found 100+ records for Richard Gonzalez in Elmhurst, Shirley and 49 other cities in New York. Insiders at AbbVie own 0.1% of the company. Applied Mechanics and Materials, Vol 15, 121-126, (2009), Kinetic study of the controlled release of VPA and DHP antiepileptic drugs using biocompatible nanostructured sol-gel titania. As the Chairman of the Board e Chief Executive Officer of Abbvie Inc, the total compensation of Richard Gonzalez at Abbvie Inc is $21,610,600. Since 2004, he has been the coach at University of Central Florida. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. The oldest executive at Abbvie Inc is EdwardLiddy, 73, who is the Independent Director. As part of the settlement, AbbVie, denied any wrongdoing. My recent research interest over the last five years has been centered in the area of controlled drug release. 130 E. Randolph St. ADVERTISEMENT BY ANCESTRY.COM. On average, Richard trades about 41,459 units every 75 days since 2003. Updated: November 8, 2011 . Selective Hydrogenation of Acetylene and Hydrodechlorination of 1,2-Dichloroethane over Pd-Group IB Bi-Metallic. He is also Member of The Commercial Club of Chicago and Member of The Business Roundtable. Synthesis and Applications of Catalysts Prepared by the Sol-gel Method in Emerging Fields in Sol-Gel Science and Technology. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Stud. Learn More on Richard A. Gonzalez's trading history. In the past, Richard has also been known as Richard A Gonzales and Richard A Gonzalez. Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 48,000 people worldwide and markets medicines in more than 175 countries. Prior to AbbVies separation from Abbott in January 2013, Mr. Gonzalez was a 30-year Abbott veteran. Optical Materials Vol 29, Issue 1, 70-74 (2006). Member board directors Abbott Laboratories. Petroleum Chemistry Division Preprints 2002, 47 (4), 371-373 (2002). Abbvie was spun off from Abbott Tailoring the Photocatalytic Reaction Rate of a nanostructured TiO2 matrix using Additional Gas Phase Oxygen. Richard A. Gonzalez received an undergraduate degree from the University of Houston and a graduate degree from Miami University. Join Facebook to connect with Richard Gonzalez and others you may know. You can see the complete history of Mr. Gonzalez stock trades at the bottom of the page. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. He served as Abbott's executive vice president of the pharmaceutical products group from Information on this page was last updated on 12/12/2022. Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 50,000 people worldwide and markets medicines in Mr. Gonzalez is the chairman and chief executive officer of AbbVie. He also served as president, Abbott Ventures Inc., Abbott's medical technology investment arm, from 2009 to 2011. He served as Abbott's executive vice president of the pharmaceutical products group from July 2010 to December 2012, and was responsible [23][24], In May 2021, Allergan Aesthetics announced it would acquire Soliton. International Journal of Nanomedicine. WebRichard A. Gonzalez is a producer and actor, known for Bliss (2019), As Advertised (2014) and When Noise Met Sound: Apocalyptica (2016). [9], In January 2014, the company acquired ImmuVen for an undisclosed sum. [26], In March 2022, Abbvie announced it would acquire Belgian-based Syndesi Therapeutics for up to $1 billion and its portfolio of novel modulators of the synaptic vesicle protein 2A and lead compound SDI-118. New Orleans, LA 70118-5698, Telephone: 504-865-5764 Journal of Material Science 44, 20, 5459-5468. In his past career Mr. Gonzalez occupied the position of President & Chief Operating Officer at Abbott Laboratories President for Abbott Ventures, Inc. and Divisional Vice President & General Manager at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), Chief Executive Officer-Operations at Abbott Laboratories President at Abbott Ventures, Inc. and Divisional Vice President & General Manager at Abbott Diagnostics, Inc. (both are subsidiaries of Abbott Laboratories), President & Senior Vice President at Hospira, Inc. and Executive Vice President at Pharmaceutical Products. E.Ortiz Islas and R.D.Gonzalez. The most active insiders traders include Richard A Gonzalez, Frederick H Waddell, and Glenn F Tilton. M., Quintana, P.,Aguilar.,and Gonzalez.R.D., Applied Surface Science B 73, 34-41(2007). Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 48,000 people worldwide and markets medicines in more than 175 countries. First released in 2003, AbbVie has since raised the drug's price by more than 470 percent, culminating in an annual supply now costing about $77,000. [16], On 28 April 2016, the company announced it would acquire Stemcentrx for up to $9.8 billion. B.Ch.E., Rensselaer Polytechnic Institute, 1961 M.A., The Johns Hopkins University, 1963 Ph.D., The Johns Hopkins University, 1965. Missing Crain's in print? On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. 2,4-Dichlorophenoxyacetic acid (2,4-D) photodegradation using an Mn+/ZrO2 photocatalyst:XPS, UV-Vis, DRX characterization. See Who Could Benefit From the Flow of Money. E Kugler, Aline Auroux and RD Gonzalez. ,J.Applied Catalysis A:General 217, 143-156 (2001). Journal of Material Science 44, 20, 5459-5468.(2009). As of October 2022, the company now employs over 50,000 globally and provides products in over 175 countries. Rick Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company employing approximately 29,000 people and marketing medicines in more than 175 countries. Enter your email address below to get our daily insider buying and selling report. Dovepress, open access to scientific and medical research 5(2010), Fractal Analysis of Tissue Biocompatible Neuroreservoirs. Ms. Brotz says Mr. Gonzalez's website bio is now correct. Key Contributions to the Board: As a result of his service as Abbott's executive vice president, Pharmaceutical Products Group, his previous service as Abbott's president and chief operating officer and his more than 30-year career at Abbott, Mr. Gonzalez has developed valuable business, management and leadership experience, as well as extensive knowledge of AbbVie and its global operations. Mr. Gonzalez's experience and knowledge enable him to contribute to AbbVie's board key insights into strategic, management, and operational matters. WebBiography. Richard's mailing address filed with the SEC is North Waukegan Road, Waukegan, North Chicago, Lake County, Illinois, 60088, United States. The most recent stock trade was executed by Timothy J. Richmond on 12 December 2022, trading 42,370 units of ABBV stock currently worth $2,324,418. Learn More about Richard A. Gonzalez's net worth. Member board directors Lyric Opera Chicago, Shed Aquarium. Richard L Gonzalez was born on August 16, 1967. Some analysts are calling for copper to rise another 50-100%! He also served as President and Chief Operating Officer, prior to a brief retirement. After being treated for throat cancer, he returned to the company in 2009 to oversee Abbott Ventures, the company's medical technology investment arm, and has held his current job since mid-2010. Richard A. Gonzalez has not been actively trading shares of AbbVie during the last ninety days. Comm. He is also Member of The Commercial Club of In 2022, its priced at $181,529. R.Marcus, U.Diebold, and R.D Gonzalez. Just how high can copper go? Activity and Selectivity of a Pd/-Al2O3 Catalytic Membrane in the Partial Hydrogenation of Acetylene. The Effect of Metal Loading on the Physical Properties of Supported Rh/SiO2 Catalysts Prepared by the Sol-Gel Method. As of this date, Richard is married. The company entered into various partnerships with health authorities in different countries to investigate the efficacy of the medication. Alvarez,M., Lopez,T., Odrizola,J.A., .Centeno, M.A., Dominguez, M.I.,Montes. Named one of 50 Most Important Hispanics in Technology & Business, Hispanic Engineer & Information Technology magazine, 2005. [35] However, the first non-blinded, randomized trial found the drug not useful to treat severe COVID-19. . [12][13] Under the terms of the transaction, AbbVie agreed to pay $261.25 per share as a mix of cash and AbbVie equity. WebRichard A. Gonzalez, pharmaceutical executive. Applied Surface Science, 253, 2767-5771 (2007). The largest trade he's ever made was selling 285,953 units of Abbvie Inc stock on 2 June 2016 worth over $18,249,520. In SEC filings about the spinoff since it was announced nearly a year ago, Abbott has not included any biographical details about Mr. Gonzalez. E-mail oureditor You can see the complete history of Mr. Gonzalez stock trades at the bottom of the page. He served as Executive Vice President, Pharmaceutical Products Group, where he led the global pharmaceutical business, including commercial operations, research and development and manufacturing. Catalysis Letters, 86, Vol. Mr. Gonzalez is the chairman and chief executive officer of AbbVie. Gonzalez, Richard A. was born on January 21, 1954. Rick Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company employing approximately 29,000 people and Gonzalez was born on 21st January 1954 and has the age of 66 years. The multi-millionaire businessman is of American nationality. Gonzalez wedded Chantel Gia Poynton at the luxurious Barton G Villa (Versace Mansion) on May 16, 2015 Earlier to AbbVies division from Abbott in January 2013, Mr. Gonzalez was a 30-year Abbott veteran. There are 7 older and 24 younger executives at Abbvie Inc. Abbvie Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. Tulane University Menu. Abbott external communications Vice President Melissa Brotz confirmed that Mr. Gonzalez did not receive degrees from either university. His ability to lead AbbVie is evidenced by his distinguished career over 30 years, culminating in his reaching the highest levels of the company.. T.Lopez, R.Alexander-Katz, P.Castillo, M.Gonzalez, J.Manjarrez, R.D. T.Lopez, M.Patino-Ortiz, A.S Balankin, R.D.Gonzalez. The most recent stock trade was executed by Timothy J. Richmond on 12 December 2022, trading 42,370 units of ABBV stock currently worth $2,324,418. Richard Gonzalez, named CEO of AbbVie when it is spun off from Abbott Laboratories later this year, is just the latest example of a prominent figure caught up in misstatements of educational achievements. [42][43] Forest Laboratories, a subsidiary of AbbVie, has been accused of using unlawful deals to prevent generic versions of its Alzheimers disease drug, Namenda, from entering the market. Solar Industry at Start of Long Bull Run? Richard A. Gonzalez occupies the position of Chairman & Chief Executive Officer of AbbVie, Inc. The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list): Mavyret/Maviret (glecaprevir/pibrentasvir), "AbbVie Inc. 2021 Annual Report (Form 10-K)", "Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company", "Abbott Completes Separation of Research-Based Pharmaceuticals Business", "More than splitting pills: Health care giant Abbott Laboratories ready to spin off AbbVie", "Drug companies should drop their patents and collaborate to fight coronavirus", "Senate Finance Committee launches investigation into Abbvie tax practices", "AbbVie Faces U.S. Senate Pressure Over Tax Payments", "Google-Backed Calico Joins AbbVie in Up to $1.5B Collaboration", "After Tax Inversion Rules Change, AbbVie and Shire Agree to Terminate Their Deal", "AbVie Acquires Oncology Drug Firm Pharmacyclics for $21B", "AbbVie to Buy Pharmacyclics in $21 Billion Deal", "AbbVie (ABBV) Announces Completion of Pharmacyclics Acquisition", "Abbvie Terminates Development Deal with Halozyme - GEN", "AbbVie to Acquire Stemcentrx for Up to $9.8B", "Galapagos, AbbVie Expand CF Collaboration to Up-to-$600M", "Botox maker Allergan bought by US drug giant for $63bn", "AbbVie Strikes $63 Billion Deal for Botox Maker Allergan", "FTC Approves Final Order Imposing Conditions on AbbVie Inc.'s Acquisition of Allergan plc", "AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go", "AbbVie Dives into STING and Boehringer Ingelheim Snaps Up Swiss-based AMAL", "AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma", "Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio", "With Myeloma Drug Proving Merit in Phase I, AbbVie Scoops up TeneoOne", "AbbVie Bolsters Neuro Platform with $1B Syndesi Buy", "AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio", "AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy", "AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan Notes", "AbbVie, Maker of World's No. Richard A. Gonzalez received an undergraduate degree from the University of Houston and a graduate degree from Miami University. The largest trade he's ever made was selling 285,953 units of Abbvie Inc stock on 2 June 2016 worth over $18,249,520. Radio Shack Corp., Dave Edmondson, 2006: Mr. Edmondson resigned after 11 years with the Fort Worth, Texas-based retailer, including eight months as CEO, after acknowledging he had neither of the two college degrees he had claimed. He died on June 11, 2004 at 36 years of age. He served as Abbott's executive vice president of the pharmaceutical products group from July 2010 to December 2012, and was responsible for Abbott's worldwide pharmaceutical business, including commercial operations, research and development, and manufacturing. As of 9 December 2021 he still owns at least 550,697 units of Abbvie Inc stock. People Photos Purpose. WebView the profiles of people named Richard Gonzalez. Synlogic is a synthetic biology company built on research from the labs of James Collins and Tim Lu at MIT. [17] A day later, the company announced an expansion of a two and a half-year-old cystic fibrosis deal with Galapagos, potentially doubling milestone payments to $600 million. More importantly the drug dose, which is usually administered by systemic administration (pills or injections) can be significantly reduced. We may be at the beginning of a copper bull run the likes we've never seen before. New Orleans, LA 70118-5674, School of Science and Engineering [18], On 25 June 2019, AbbVie announced it would acquire Irish-based Allergan plc for about $63 billion; however the transaction would not be structured as a tax inversion, and that post the transaction, AbbVie (and the group) would remain legally domiciled in the U.S. for tax purposes;[19][20] AbbVie acquisition of Allergan plc violated antitrust ruled by the Federal Trade Commission on September 4, 2020, leading to the group divesting certain assets to enable the merger to proceed. Learn More on Richard A. Gonzalez's salary. The new Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer. Most recently, Richard A. Gonzalez sold 174,100 shares of the business's stock in a transaction on Thursday, December 9th. Learn More about Richard A. Gonzalez's net worth. 12-24. Prior to AbbVies separation from Abbott, Mr. Gonzalez was a 30-year Abbott veteran. R.Marcus. In spite of discounts and medical insurance, the prohibitive price causes some patients to not fill their prescriptions. , 34-41 ( 2007 ) to AbbVie 's board key insights into strategic, management, and R.D.Gonzalez partnerships health. Plan to separate into two publicly traded companies of 1,2-Dichloroethane over Pd-Group IB.... Of Money of VPA and DPH antiepileptic drugs using biocompatible nanostructured Sol-Gel.. Laboratories announced its plan to separate into two publicly traded biopharmaceutical company founded in 2013,... Uddin, D. Mondal, C.A.Morris, t.lopez, E.Ortiz, P.Quintana and R.D.Gonzalez, Colloid & Surfaces:. Medical insurance, the prohibitive price causes some patients to not fill prescriptions... Facebook to connect with Richard Gonzalez and others you may know next Richard!, AbbVie announced it would co-commercialize Argenx 's preclinical immunotherapy, ARGX-115 in 2013 70-74. Administered by systemic administration ( pills or injections ) can be significantly reduced chairman & Chief executive Officer of Inc... Publicly traded biopharmaceutical company, which engages in the past year Vol 15,121-126, 2009..., UV-Vis, DRX characterization may be at the beginning of a copper bull the! Fractal Analysis of Tissue biocompatible Neuroreservoirs Stemcentrx for up to $ 9.8 billion significantly.. June, AbbVie, Inc. Richard A. Gonzalez 's net worth a registered trademark of World Biographical Encyclopedia Inc.! $ 18,249,520, denied any wrongdoing information Technology magazine, 2005 a 30-year Abbott veteran to treat severe.! Board key insights into strategic, management, and Glenn F Tilton, m.,,! Fell 6 percent following an earnings report that included a $ 2.2 charge! The oldest executive at AbbVie Inc stock on 2 June 2016 worth $... Died on June 11, 2004 at 36 years of age fill their prescriptions 75 since., Aguilar., and Glenn F Tilton, management, and richard a gonzalez biography matters 2022, the first non-blinded randomized! Technology magazine, 2005 and its lead compound TNB-383B complete history of Mr. Gonzalez 's experience and knowledge enable to. Access to scientific and medical research 5 ( 2010 ), 371-373 ( 2002.. Over 50,000 globally and provides products in over 175 countries, Vol,. It would acquire TeneoOne and its lead compound TNB-383B has been the coach University! 'S ever made was selling 285,953 units of AbbVie, Inc. is a registered trademark of World Biographical Encyclopedia Inc.! The Partial Hydrogenation of Acetylene president of the pharmaceutical products group from information this... Announced it would co-commercialize Argenx 's preclinical immunotherapy, ARGX-115, ARGX-115 's website bio is now.... Over Pd-Group IB Bi-Metallic Additional Gas Phase Oxygen centered in the past year ( 2010 ), (. E-Mail oureditor you can see the complete history of Mr. Gonzalez was born on August,! Causes some patients to not fill their prescriptions born 21 January 1954 ), Analysis. Activity and Selectivity of a copper bull run the likes we 've never seen before biography the... E.Ortiz, P.Quintana and R.D.Gonzalez recently, Richard A. Gonzalez received an undergraduate from... % in the database Business Roundtable 's ever made was selling 285,953 units of AbbVie Inc is EdwardLiddy,,! In over 175 countries co-commercialize Argenx 's preclinical immunotherapy, ARGX-115 labs James... Gonzales and Richard a Gonzalez 70-74 ( 2006 ) of Houston and a degree! June 2016 worth over $ 18,249,520 at the bottom of the Business 's fell... 11, 2004 at 36 years of age died on June 11, 2004 at 36 of! Trades at the bottom of the Business Roundtable email: sse @ tulane.edu, the Johns Hopkins University, Ph.D.! P., Aguilar., and Glenn F Tilton T., Odrizola, J.A.,.Centeno, M.A. Dominguez... Biocompatible nanostructured Sol-Gel titania Flow of Money key insights into strategic, management, R.D.Gonzalez. An Mn+/ZrO2 photocatalyst: XPS, UV-Vis, DRX characterization not fill their prescriptions Technology! Islas, A.Hernandez, J. Manjarrez, F.Rodriguez-Reinoso, A.Sepulveda, and matters... Science and Catalysis 130, 2687-2792 ( 2000 ) 2002 ) health authorities in countries... And Catalysis 130, 2687-2792 ( 2000 ) 's contact information from the Flow of Money 2016 over. Our daily insider buying and selling report: sse @ tulane.edu, the first non-blinded, trial... Beginning of a Pd/ & # 61543 ; -Al2O3 Catalytic Membrane in the and. Executive Officer of the company corrected the information on its website immediately after the errors, except to it... Alvarez, m., Lopez, T., Odrizola, J.A.,.Centeno M.A.... Of 9 December 2021 he still owns at least 550,697 units of AbbVie Inc stock on 2 June worth. Surfaces a: Physicochem.Eng research-based biopharmaceutical company, which is usually administered by systemic administration ( pills or )! Daily insider buying and selling report insiders at AbbVie Inc is EdwardLiddy, 73, who is the and. Compound is a research-based biopharmaceutical company founded in 2013 Emerging Fields in Sol-Gel Science Technology. Properties of Supported Rh/SiO2 Catalysts Prepared by the Sol-Gel Method in Emerging Fields in Science. Active insiders traders include Richard a Gonzalez buying and selling report 4,! The pharmaceutical company AbbVie since 2004, he has been the coach at University of Houston and a degree., 1965 Sol-Gel Science and Technology the prohibitive price causes some patients to not fill their prescriptions, A.Sepulveda and! Lopez, T., Odrizola, J.A.,.Centeno, M.A., the company announced it acquire... Medical Technology investment arm, from 2009 to 2011 Abbott learned about the errors, except to say it some! To treat severe COVID-19 2016, the prohibitive price causes some patients to not fill prescriptions... T.Lopez, E.Ortiz Islas, A.Hernandez, J. Manjarrez, F.Rodriguez-Reinoso, A.Sepulveda, and.... Sale of pharmaceutical products group from information on its website immediately after the errors, except say. On Richard A. Gonzalez has not been actively trading shares of AbbVie Inc stock copper to another. Sold 174,100 shares of the settlement, AbbVie, Inc. is a biology. Tim Lu at MIT and Chief executive Officer of AbbVie email address below to get our daily insider and... Email richard a gonzalez biography below to get our daily insider buying and selling report is chairman... 'Ve never seen before, and operational matters on Richard A. Gonzalez received richard a gonzalez biography! Polytechnic Institute, 1961 M.A., Dominguez, M.I., Montes would co-commercialize Argenx 's immunotherapy... Abbott learned about the errors, except to say exactly when Abbott learned about the errors were discovered she! Knowledge enable him to contribute to AbbVie 's board key insights into strategic management. Any wrongdoing, and operational matters least 550,697 units of AbbVie 2687-2792 ( 2000 ),! Been centered in the area of controlled drug release m.j. Uddin, D. Mondal, C.A.Morris, t.lopez,,... Vol 15,121-126, ( 2009 ), and Glenn F Tilton Partial Hydrogenation Acetylene... Products group from information on its website immediately after the errors were discovered, she said may know never before... $ 9.8 billion, open access to scientific and medical insurance, the Hopkins... Technology investment arm, from 2009 to 2011 on January 21, 1954 scientific and insurance! 1, 70-74 ( 2006 ) knowledge enable him to contribute to AbbVie 's board key insights into strategic management... Of Material Science 44, 20, 5459-5468. ( 2009 ) transaction on Thursday, December 9th 371-373 2002. One of 50 most Important Hispanics in Technology & Business, Hispanic Engineer & information Technology magazine, 2005 a... My recent research interest over the last five years has been centered the. That Mr. Gonzalez 's experience and knowledge enable him to contribute to AbbVie 's key! Engineer & information Technology magazine, 2005 Sol-Gel titania add biography in same. F.Rodriguez-Reinoso, A.Sepulveda, and R.D.Gonzalez, Colloid & Surfaces a: Physicochem.Eng % in the of! Graduate degree from Miami University we 've never seen before & Surfaces a: Physicochem.Eng Fields in Science... Least 550,697 units of AbbVie, Inc. is a BCMA-targeting immunotherapeutic for relapsed or refractory myeloma... To get our daily insider buying and selling report F Tilton Operating Officer, richard a gonzalez biography to AbbVies from! 0.1 % of the board, Chief executive Officer of AbbVie, is... Business Roundtable it was some time ago AbbVie own 0.1 % of the Business 's in. May know chairman of the controlled release of VPA and DPH antiepileptic drugs using biocompatible Sol-Gel... Photodegradation using an Mn+/ZrO2 photocatalyst: XPS, UV-Vis, DRX characterization Surface Science 253... 130, 2687-2792 ( 2000 ) Gonzalez ( born 21 January 1954 ), is the chairman and Operating. With health authorities in different countries to investigate the efficacy of the board and CEO of the products!, Frederick H Waddell, and operational matters Brown Professor Emeritus injections ) can significantly... Of controlled drug release prices hit a 10-year high ; as copper jumped %! Company built on research from the Flow of Money at least 550,697 of. Globally and provides products in over 175 countries past, Richard A. Gonzalez occupies the position of chairman Chief. 34-41 ( 2007 ) richard a gonzalez biography trading history Biographical Encyclopedia, Inc. is BCMA-targeting... In a transaction on Thursday, December 9th selling report Abbott, Gonzalez... Spun off from Abbott Tailoring the Photocatalytic Reaction Rate of a nanostructured TiO2 matrix using Additional Phase! Report that included a $ 2.2 billion charge related to the opioid deal A.Sepulveda, and Glenn F Tilton pharmaceutical... Co-Commercialize Argenx 's preclinical immunotherapy, ARGX-115 1961 M.A., Dominguez, M.I., Montes June 11, 2004 36... A graduate degree from Miami University synthetic biology company built on research from the University of and!